Category | Part A | Part B | Part C | Total |
---|---|---|---|---|
Preferred Term | (N = 12) | (N = 10) | (N = 10) | (N = 32) |
N (%) | N (%) | N (%) | N (%) | |
Subjects with Any Adverse Event | 1 (8.3) | 3 (30.0) | 7 (70.0) | 11 (34.4) |
Subjects with Any Study Drug Related Adverse Event | 0 (0.0) | 0 (0.0) | 1 (10.0) | 1 (3.1)a |
Subjects with Any Serious Adverse Event | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Subjects with Any Study Drug Related Serious Adverse Event | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |
Subjects with Any Adverse Event Leading to Discontinuation | 0 (0.0) | 0 (0.0) | 0 (0.0) | 0 (0.0) |